Consolidated Statements of Operations - USD ($)	3 Months Ended
	Dec. 31, 2025	Dec. 31, 2024
Consolidated Statements of Operations
Revenues, net	$ (1,207,833)
Cost of revenues	29,626
Gross profit	(1,237,459)
Operating expenses:
Research and development	3,634,352	$ 9,660,150
Selling, general and administrative	8,612,141	11,946,702
Loss from operations	(13,483,952)	(21,606,852)
Loss on equity method investment	38,634	33,295
Interest income	0	(48,881)
Loss from change in fair value of promissory notes	6,743,736	1,304,000
Loss (gain) from change in fair value of warrant liability	2,791,813	(40,272,880)
Net (loss) income	$ (23,058,135)	$ 17,377,614
Per share information:
Net (loss) income per share of common stock, basic (in dollars per share)	$ (0.38)	$ 0.72
Net (loss) income per share of common stock, diluted (in dollars per share)	$ (0.38)	$ 0.72
Weighted average shares outstanding, basic (in shares)	60,205,035	24,233,957
Weighted average shares outstanding, diluted (in shares)	60,205,035	24,233,957